ANDA 213852, held by Rhodes Pharms. Amphetamine Sulfate.
As of Nov 16, 2026, ANDA 213852 (Amphetamine Sulfate), held by Rhodes Pharms, was first approved by FDA on Sep 7, 2021, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 7, 2021 | Original application | Approved | None posted |
| Amphetamine Sulfate5MG · tablet;oral | Amphetamine Sulfate | Discontinued |
| Amphetamine Sulfate10MG · tablet;oral | Amphetamine Sulfate | Discontinued |
| Oct 18, 2023 | Supplement 2Labeling · Standard review | Approved | None posted |
| Feb 25, 2022 | Supplement 1Labeling · Standard review | Approved | None posted |
| Sep 7, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters